Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.14
-0.01 (-0.87%)
At close: Oct 06, 2025, 11:16 AM
Trinity Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -37.28M | -31.79M | -20.34M | -22.3M | -21.53M | -24.02M | -28.6M | -30.82M | -46.8M | -41.01M | -25.2M | -14.03M | 12.4M | 14.02M | 15.39M | 22.89M | 19.74M |
Depreciation & Amortization | 1.81M | 1.87M | 1.9M | 1.53M | 1.87M | 1.78M | 1.98M | 2.5M | 2.27M | 2.37M | 3.53M | 3.59M | 4.33M | 4.43M | 2.6M | 2.5M | 2.3M |
Stock-Based Compensation | 504K | 1.32M | 167K | 655K | 1.52M | 2.07M | 4.39M | 3.77M | 2.92M | 1.75M | 596K | 729K | 920K | 1.1M | 1.23M | 1.14M | 1.04M |
Other Working Capital | 9.28M | 4.07M | -58K | -505K | -3.47M | -2.69M | -1.03M | 1.45M | 527K | 609K | -816K | -2.75M | -3.69M | -573K | -3.1M | -3.88M | 750K |
Other Non-Cash Items | 18.81M | 17.81M | 11.19M | 12.18M | 10.01M | 11.37M | 15.64M | 21.05M | 44.14M | 38.56M | 29M | 21.49M | -3.37M | -3.71M | -7.22M | -8.46M | -8.4M |
Deferred Income Tax | 419K | 419K | -166K | 91K | -45K | -56K | -72K | -291K | -53K | -42K | -26K | -29K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 11.4M | 6.19M | -58K | -505K | -3.47M | -2.69M | -2.87M | -393K | -1.3M | -1.22M | -5.2M | -7.13M | -8.09M | -4.98M | 7.06M | 6.29M | 10.91M |
Operating Cash Flow | -4.34M | -4.19M | -7.3M | -8.34M | -11.66M | -11.56M | -9.53M | -4.18M | 1.19M | -477K | 1.65M | 2.51M | 2.77M | 8.76M | 16.83M | 22.32M | 23.85M |
Capital Expenditures | -8.66M | -10.06M | -8.22M | -6.14M | -3.54M | -2.7M | -2.95M | -3.65M | -4.12M | -5.98M | -7.92M | -9.28M | -11.12M | -10.83M | -12.04M | -12.04M | -11.33M |
Cash Acquisitions | -404K | -12.9M | -12.9M | -12.77M | 15.66M | 28.16M | 28.16M | 28.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -700K | -700K | -700K | -700K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -8.26M | -8.26M | -5.68M | -3.85M | 27.25M | 26.2M | 25.54M | 25.29M | -4.38M | -3.34M | 166K | 2.26M | 1.76M | 3.97M | 5.51M | 3.63M | 5.75M |
Investing Cash Flow | -10.99M | -22.97M | -21.12M | -18.91M | 12.12M | 24.76M | 24.51M | 24.07M | -4.82M | -5.98M | -5.08M | -6.44M | -8.28M | -7.99M | -7.66M | -7.67M | -6.95M |
Debt Repayment | 10.56M | 27.67M | 25.78M | 25.89M | 9.5M | -7.37M | -7.41M | -7.52M | -12.26M | -23.91M | -24.13M | -24.15M | -9.66M | -2.96M | -3.02M | -3.11M | -3.15M |
Common Stock Repurchased | -270K | -270K | -270K | -270K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.99M | -6.25M | -7.39M | -7.05M | -8.03M | -8.68M | -8.27M | -8.1M | -10.6M | -13.42M | -17.59M | -15.9M | -12.43M | -5.2M | -4.59M | -4.59M | -73K |
Financial Cash Flow | 13.78M | 28.81M | 25.24M | 18.57M | 1.2M | -16.04M | -16.12M | -16.06M | -2.13M | -12.76M | -16.7M | -15.03M | -17.51M | -9.18M | -8.64M | -8.73M | -4.99M |
Net Cash Flow | -1.71M | 1.48M | -3.42M | -8.91M | 1.62M | -2.89M | -993K | 3.77M | -5.86M | -19.33M | -20.22M | -18.16M | -22.27M | -1.42M | 7.57M | 13.05M | 19.03M |
Free Cash Flow | -12.99M | -16.26M | -18.73M | -17.69M | -18.41M | -15.47M | -12.48M | -7.84M | -2.94M | -6.46M | -6.27M | -6.76M | -8.35M | -2.07M | 4.79M | 10.27M | 12.52M |